ReviewDrug design, development and therapy2022

Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data.

Larissa Hauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.